TOPIX pharmaceutical-grade skin care formulations have been trusted by dermatologists and their patients for over three decades. Our reputation for quality and innovation begins in the laboratory, and echoes throughout our products. We have harnessed the greatest potency of antioxidants through green tea polyphenols, effectively soothing skin to help achieve maximum efficacy without irritation. TOPIX is dedicated to delivering innovative, clinically relevant topical skin care solutions that meet the needs of direct-dispensing physician partners and their patients. Empowering people of all ages & skin types with trusted, consistent results for healthy, beautiful skin.
View Top Employees from Topix Pharmaceuticals, Inc.Website | http://www.topixpharm.com |
Revenue | $66 million |
Employees | 174 (166 on RocketReach) |
Founded | 1981 |
Address | 174 Route 109, West Babylon, New York 11704, US |
Phone | (631) 225-5757 |
Technologies |
JavaScript,
HTML,
Twitter
+35 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Cosmetics, Beauty Supply & Personal Care Products, Pharmaceutical, Developing, Consumer Goods, Health Care, Manufacturing And Marketing Innovative Therapeutic And Cosmetic , Manufacturing, Product Design, Design, Therapeutics |
Web Rank | 2 Million |
Keywords | Anti-Aging |
Competitors | Crown Laboratories, Inc., HATCHBEAUTY Brands, Lornamead, Uelzena eG, Worldmark |
SIC | SIC Code 28 Companies, SIC Code 284 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3256 Companies, NAICS Code 325611 Companies, NAICS Code 325 Companies, NAICS Code 32561 Companies |
Looking for a particular Topix Pharmaceuticals, Inc. employee's phone or email?
The Topix Pharmaceuticals, Inc. annual revenue was $66 million in 2024.
Paul Carousso is the CFO of Topix Pharmaceuticals, Inc..
166 people are employed at Topix Pharmaceuticals, Inc..
Topix Pharmaceuticals, Inc. is based in West Babylon, New York.
The NAICS codes for Topix Pharmaceuticals, Inc. are [32, 3256, 325611, 325, 32561].
The SIC codes for Topix Pharmaceuticals, Inc. are [28, 284].